
The ACT government is considering legislation changes to allow MDMA-assisted therapy to treat post-traumatic stress disorder and psilocybin to treat depression.
Currently, ACT legislation applies the Australian Therapeutic Goods Administration decisions, which ruled against rescheduling psychedelics late last year.